Differential Diagnosis of Low CD4 Count

Primary Approach: HIV Status Determination

The Centers for Disease Control and Prevention (CDC) recommends using HIV testing algorithms for proper interpretation based on assays employed 1
HIV infection is the most common cause of low CD4 counts and must be ruled out first with serologic testing, especially in patients who are asymptomatic or have very low viral loads 1
Confirm HIV status even in patients with previous negative tests or questionable documentation, as patients may present with misinformation regarding test results 1

The American Academy of Allergy, Asthma, and Immunology suggests suspecting Idiopathic CD4 Lymphocytopenia (ICD4L) in patients with opportunistic infections and persistent CD4 counts <300 cells/mL in the absence of HIV or other identifiable causes 2
ICD4L typically presents in the third and fourth decades of life 2
Autoimmunity occurs in 23% of patients with ICD4L, most frequently systemic lupus erythematosus 2
The American Academy of Allergy, Asthma, and Immunology recommends investigating DiGeorge Syndrome (DGS) in patients with thymic hypoplasia, cardiovascular structural defects, midline craniofacial defects, and hypoparathyroidism 2

Chemotherapy and immunosuppressive agents can cause CD4 depletion 1
Hematologic malignancies can directly affect lymphocyte production and distribution 1
Lymphoma (primary CNS or systemic with CNS involvement) should be considered in severely immunocompromised patients 3

The Infectious Diseases Society of America recommends considering CD4 percentage, which is more consistent than absolute CD4 count with successive measurements 1
Absolute CD4 counts are derived from three separate measurements, introducing multiple sources of variability 4
Biological variability includes approximately 10% diurnal variation and 13% week-to-week variation 4

The American Thoracic Society suggests that patients with CD4 >200 cells/µL are very unlikely to have Pneumocystis pneumonia and other opportunistic infections 5
Patients with CD4 <200 cells/µL are at high risk for Pneumocystis jirovecii pneumonia requiring prophylaxis 3
The CDC recommends suspecting opportunistic infections even when chest radiograph findings are normal in patients with CD4 <200 cells/µL 5
The American Thoracic Society suggests that CD4 <150 cells/µL is associated with an increased risk for toxoplasmosis, histoplasmosis, and cryptococcosis 3
CD4 <100 cells/µL is a risk threshold for disseminated fungal infections and cerebral toxoplasmosis 3
CD4 <50 cells/µL is associated with a risk for disseminated Mycobacterium avium complex 3

The Infectious Diseases Society of America recommends not assuming HIV-negative status without confirmatory testing 1
The American Academy of Allergy, Asthma, and Immunology suggests avoiding relying solely on absolute CD4 counts without considering CD4 percentage 4
The American Thoracic Society recommends not dismissing the possibility of opportunistic infections in patients with normal chest radiographs if CD4 <200 cells/µL 5
The CDC suggests considering geographic factors in the differential diagnosis, as endemic tuberculosis and fungi predispose to invasive infections 5
The Infectious Diseases Society of America recommends recognizing that laboratory markers may not reflect disease severity in severely immunocompromised patients due to blunted inflammatory responses 3
The American Academy of Allergy, Asthma, and Immunology suggests maintaining a broad differential diagnosis as multiple concurrent conditions are possible 3
The Infectious Diseases Society of America recommends repeating CD4 measurements to confirm persistent lymphopenia before extensive workup 1
The CDC suggests evaluating for anergy in patients with suspected tuberculosis, as cutaneous anergy may be present in >10% of asymptomatic persons with CD4 >500 cells/µL and >60% with CD4 <200 cells/µL 8